Wei Yan
Impact in
- Immunology top 5%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune Response and Inflammation
- Immune cells in cancer
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
Papers in
-
- Inflammasome and immune disorders 5
- RNA Research and Splicing 4
- Epidemiology 14
- Liver Disease Diagnosis and Treatment 6
- Hepatitis B Virus Studies 4
- Co-authors
- Dean Tian (38 shared papers)Allan Tsung (4 shared papers)Yu Fu (9 shared papers)Hai Huang (4 shared papers)Ping Han (16 shared papers)Mei Liu (16 shared papers)Su Zhou (17 shared papers)Michael T. Lotze (2 shared papers)
- Journals
- International Immunopharmacology (4 papers)Hepatology (3 papers)PLoS ONE (3 papers)Frontiers in Immunology (3 papers)Clinical and Translational Medicine (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Wei Yan
86 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 113
- Immunology 730
- Cancer Research 411
- Hepatology 201
- Clinical Biochemistry 181
- Aging 36
Countries citing papers authored by Wei Yan
This map shows the geographic impact of Wei Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Yan more than expected).
Fields of papers citing papers by Wei Yan
This network shows the impact of papers produced by Wei Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Yan. The network helps show where Wei Yan may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 301 | |
| 2 | 2015 | 219 | |
| 3 | 2012 | 202 | |
| 4 | 2013 | 190 | |
| 5 | 2020 | 96 | |
| 6 | 2022 | 83 | |
| 7 | 2012 | 82 | |
| 8 | 2009 | 81 | |
| 9 | 2019 | 75 | |
| 10 | 2017 | 70 | |
| 11 | 2022 | 67 | |
| 12 | 2016 | 63 | |
| 13 | 2008 | 62 | |
| 14 | The contrasting roles of inflammasomes in cancer. | 2018 | 52 |
| 15 | 2014 | 51 | |
| 16 | 2018 | 47 | |
| 17 | 2020 | 47 | |
| 18 | 2020 | 45 | |
| 19 | 2015 | 43 | |
| 20 | Netrin-1 promotes cell migration and invasion by down-regulation of BVES expression in human hepatocellular carcinoma. | 2015 | 43 |
About Wei Yan
Wei Yan is a scholar working on Molecular Biology, Epidemiology, Immunology, Hepatology and Cancer Research, having authored 91 papers that have together received 2.9k indexed citations. Recurring topics across this work include Reproductive Biology and Fertility (9 papers), Liver Diseases and Immunity (7 papers), Liver Disease Diagnosis and Treatment (6 papers), Effects and risks of endocrine disrupting chemicals (5 papers), Inflammasome and immune disorders (5 papers), Axon Guidance and Neuronal Signaling (5 papers), Hepatitis B Virus Studies (4 papers) and RNA Research and Splicing (4 papers). The work is most often cited by research in Immunology (730 citations), Cancer Research (411 citations), Hepatology (201 citations), Clinical Biochemistry (181 citations) and Aging (36 citations). Wei Yan has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Dean Tian, Allan Tsung, Yu Fu, Hai Huang, Ping Han, Mei Liu, Su Zhou, Michael T. Lotze, Gary Nace and Timothy R. Billiar. Their work appears in journals such as International Immunopharmacology, Hepatology, PLoS ONE, Frontiers in Immunology and Clinical and Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.